Our News
All the latest company news, views and insight from the Beckley Psytech team.
Enhancing the accessibility of psychedelic healthcare
‘The combination of the drug and psychotherapy is critical. What will be interesting to see is how the healthcare infrastructure reacts to that. That will vary around the world because different healthcare systems are set up differently and mental ... Read More
Brunch with Sifted: Amanda Feilding and Cosmo Feilding-Mellen on the psychedelic renaissance
“The logic behind setting up Beckley Psytech was that there’s this body of evidence that’s been generated in an academic setting, in early stage, proof of concept settings. Now the next step is to actually take these drugs through the drug deve... Read More
Beckley Psytech to present at Jefferies 2021 London Healthcare Conference
Cosmo Feilding Mellen, Chief Executive Officer, will present at the Jefferies 2021 London Healthcare Conference, taking place in-person and virtually from 16th to 19th November, 2021.
“Unlocking the therapeutic potential of psychedelic medicine is not just a business for us, it is ...
Expert interview with Cosmo Feilding-Mellen on Beckley Psytech’s longstanding involvement in the psychedelic medicine space and best-in-class drug development team.
Beckley Psytech’s Commercial Director Becky Verity explores the potential of digital therapeutics in mental health treatment.
Spotlight on the psychedelic experience
We continue our look back at the heritage of the Beckley Foundation’s ground-breaking research programmes and the potential for Beckley Psytech, which leverages the Foundation’s knowledge and research capabilities through a close strategic partne... Read More